Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
AMRX
Amneal Pharmaceuticals Inc. AMRX
$16.15
โ–ผ -0.86% 24H
1.337.0212.7118.4024.092018-052020-052022-052024-062026-06

About

Amneal Pharmaceuticals Inc. is a global biopharmaceutical company that develops, manufactures, and distributes a diverse portfolio of essential medicines across three reportable segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers a broad range of generic pharmaceuticals in varโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees8,700
TickerAMRX

Statistics

Market Cap$5.15B
Revenue (TTM)$3.02B
Net Income$72.1M
Net Margin2.4%
EPS$0.22
P/E44.16
P/S1.71
P/B-112.16
EV/EBITDA11.18
ROE-101.0%
Dividend Yieldโ€”
Price$16.15

Data: Twelve Data ยท Revenue = mcap / P/S

Amneal Pharmaceuticals Inc. (AMRX) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap